J. Joy Lee, MD, and colleagues at Stanford University in Palo Alto, Calif., accessed the California Cancer Registry for all incident cases of RCC from 2001-2005. Of 17,216 patients, 5,493 presented with stage T1 tumors.
Compared with whites, Hispanics and Asian-Pacific Islanders had a significant 20% and 28% decreased likelihood of undergoing PN. Compared with patients in the highest quintile of SES, those in the first, second, and third quintiles had a significant 38%, 21%, and 34% decreased odds of undergoing PN.
Continue Reading
In addition, compared with privately insured patients, Medicare patients were 41% less likely to undergo PN.
Enjoying our content?
Thanks for visiting Renal & Urology News. We hope you’re enjoying the latest clinical news, full-length features, case studies, and more.
You’ve viewed {{metering-count}} of {{metering-total}} articles this month. If you wish to read unlimited content, please log in or register below. Registration is free.
{{login-button}} {{register-button}}
Log in to continue reading this article.
Don’t miss out on today’s top content on Renal & Urology News. Register for free and gain unlimited access to:
- Clinical News, with personalized daily picks for you
- Case Studies
- Conference Coverage
- Full-Length Features
- Drug Monographs
- And More
{{login-button}} {{register-button}}
Want to read more?
Please login or register first to view this content.